Cargando…

Valproate-induced hypothyroidism in schizoaffective disorder

INTRODUCTION: Valproate is widely used in the treatment of maniac and mixed episodes and is well known to be safe with side effects being mostly related to hepatic disorders and psychomotor retardation. OBJECTIVES: Raising attention to valproate-induced hypothyroidism that despite the increasing evi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Facucho-Oliveira, J., Espada-Santos, P., Fraga, A., Moura, N., Laginhas, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568215/ http://dx.doi.org/10.1192/j.eurpsy.2022.1862

Ejemplares similares

Transcranial magnetic stimulation and post-traumatic stress disorder
por: Moura, N., et al.
Publicado: (2022)

How to manage antipsychotic-induced akathisia
por: Moura, N., et al.
Publicado: (2021)

Valproate-induced severe symptomatic hyponatremia in a patient with schizoaffective disorder: a case study and literature review
por: Heflin, K., et al.
Publicado: (2023)

Behavioural Variant of Frontotemporal Dementia or Mood Disorder?
por: Mesquita, B., et al.
Publicado: (2022)

Mechanisms linking gut microbiota to depression
por: Fraga, A., et al.
Publicado: (2021)

The role of Mediterranean Diet in mental health in pandemic times
por: Fraga, A., et al.
Publicado: (2021)

Effects of psilocybin-assisted therapy on treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)

COVID-19 Psychiatric Inpatient Unit- experience and challenges
por: Mesquita, B., et al.
Publicado: (2022)

Ketamine and Electroconvulsive Therapy: Better Together?
por: Fraga, A., et al.
Publicado: (2022)

Lithium: more than a mood stabilizier
por: Fraga, A., et al.
Publicado: (2022)

The role of intranasal esketamine in treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)

Aripiprazol and Hypersexuality: when partial is to much
por: Espada-Santos, P., et al.
Publicado: (2022)

Schizoaffective disorder about 57 cases
por: Kammoun, I.
Publicado: (2021)

Schizoaffective disorder induced by substance abuse: a case report
por: García Carpintero, A., et al.
Publicado: (2022)

The Role of Vagus Nerve Stimulation in Depression: What We Know?
por: Fraga, A., et al.
Publicado: (2022)

Irritable Bowel Syndrome: The role of the Psychiatry
por: Fraga, A., et al.
Publicado: (2022)

Neuropsychiatric symptoms of multiple sclerosis: A case report
por: Dos Santos, P. Espada, et al.
Publicado: (2021)

Clinical factors affecting functioning in patients with schizophrenia or schizoaffective disorder
por: Neily, C., et al.
Publicado: (2022)

The use of technologies and social media in patients with schizophrenia and schizoaffective disorder
por: Elleuch, O., et al.
Publicado: (2022)

Schizoaffective disorder: Nosological controversies and absence of specific treatment guidelines
por: García, M. Valtueña, et al.
Publicado: (2021)

Novel use of granulocyte colony stimulating factor as an adjunct for treatment of schizoaffective disorder complicated by sodium valproate induced agranulocytosis
por: Subbarayan, S., et al.
Publicado: (2012)

Clinical case of religious delusion in a combination of schizoaffective disorder and epilepsy
por: Gedevani, E., et al.
Publicado: (2022)

Impact of somatic and addictive comorbidities on the quality of life of patients with schizoaffective disorder
por: Bouali, W., et al.
Publicado: (2023)

Religious Coping Strategies for Religious Patients with Schizophrenia and Schizoaffective Disorder
por: Gedevani, E., et al.
Publicado: (2022)

Severe fatigue due to valproate-induced hypothyroidism in a case of bipolar disorder
por: Kanamori, Tadashi, et al.
Publicado: (2020)

First episode psychosis: the depressive symptoms and suicidal behaviour that follow
por: Mesquita, B. L. B., et al.
Publicado: (2023)

Mindfullness-Based Interventions for Anxiety and Depression
por: Mesquita, B. L. B., et al.
Publicado: (2023)

Risk assessment of agressive behavior in schizophrenia and schizoaffective disorder : a cross-sectional study
por: Mellouli, A., et al.
Publicado: (2023)

Socio-demographic, clinical and therapeutic features of patients treated for schizoaffective disorder using cannabis
por: Bouali, W., et al.
Publicado: (2023)

Valproate induced encephalopathy: Paradigm of normal ammonia levels
por: Barbosa, P., et al.
Publicado: (2021)

PM395. The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Na, Kyoungsae, et al.
Publicado: (2016)

CT abnormalities in late-onset schizophrenia and schizoaffective disorder correlate with number of psychotic episodes and cognitive dysfunction
por: Savina, M., et al.
Publicado: (2021)

Valproate-induced hyperammonemic encephalopathy. A case report
por: Cerame, A., et al.
Publicado: (2022)

How sexuality is affected and managed in patients under antipsychotic drugs
por: Ribeirinho Soares, F., et al.
Publicado: (2023)

Diagnostic challenges presented by women with anorexia nervosa and elevated rates of autistic traits
por: Jeremias, D., et al.
Publicado: (2021)

Should schizoaffective disorder be diagnosed cross-sectionally (ICD-11) instead of longitudinally (DSM-5)?: PRO
por: Falkai, P.
Publicado: (2021)

Hypothyroidism may exacerbate valproate-related hyperammonemic delirium
por: Hung, Chung-Chieh, et al.
Publicado: (2016)

SCHIZOAFFECTIVE DISORDER : CONSISTENCY OF DIAGNOSIS
por: Shrivastava, Amresh, et al.
Publicado: (1999)

Schizoaffective Disorder and Concurrent Rhabdomyolysis
por: Varkey, Thomas, et al.
Publicado: (2021)

To live with a Schizoaffective disorder
por: Arndtzén, Mats, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g31ij3r3a99up2qq019c5r4c57